pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER
Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
IIBSP-PRE-2024-198
Phase 3 · small molecule · intrauterine growth restriction, preeclampsia
IIBSP-PRE-2024-198 for intrauterine growth restriction, preeclampsia is a Phase 3 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Internal code IIBSP-PRE-2024-198
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The George Institute
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- intrauterine growth restriction, preeclampsia
- Status
- active
- Trials
- 1